Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Roche with its 2024 acquisition of Carmot, and Pfizer, following its 2025 acquisition of Metsera, enter obesity and broaden their presence in cardiovascular/metabolic, while other large pharmaceutical companies prepare to follow later in the decade
PMC 2938802
Most of the time, adverse effects go away when you stop using the drug, especially if you catch them early
While some patients tolerate treatment well when appropriately evaluated, safety depends on individual health status, medications, and clinical judgment
If a complex model performs only marginally better than standard clinical assessment, its implementation burden may not be justified
US$ 20.10
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
US$ 27.36
US$ 26.57
US$ 22.14
US$ 26.10
US$ 23.38
